Call to Schedule(864) 558-7346
A clinic blog claims Russia will roll out an AI-designed, personalized mRNA cancer vaccine as early as 2025, possibly free to patients. The story cites pre-clinical results only—no peer-reviewed human data, no clear regulator path—so treat this as a watch-list item, not practice-changing news. If real trials appear with solid outcomes, then it gets interesting; until then, it’s headline heat more than clinical light.
